Retinitis Pigmentosa Research Advances
July 02, 2025
July 02, 2025
COLUMBIA, Maryland, July 2 -- The Foundation Fighting Blindness issued the following news:
* * *
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmentosa.
*
JOHNSON & JOHNSON REPORTS RESULTS FOR PHASE 3 XLRP GENE THERAPY CLINICAL TRIAL
J&J announced that bota-vec, its gene therapy for X-linked RP, didn't meet its primary endpoint (ability to navigate a maze under diffe . . .
* * *
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmentosa.
*
JOHNSON & JOHNSON REPORTS RESULTS FOR PHASE 3 XLRP GENE THERAPY CLINICAL TRIAL
J&J announced that bota-vec, its gene therapy for X-linked RP, didn't meet its primary endpoint (ability to navigate a maze under diffe . . .